Governance framework for AI in healthcare across Southeast Asia, addressing patient consent, health data privacy, and regulatory compliance.
Patient safety: AI clinical decisions must not compromise patient outcomes
Privacy by design: Protect patient health information (PHI) throughout AI lifecycle
Clinical validation: AI diagnostic/treatment tools undergo rigorous clinical testing
Transparency: Clinicians understand AI recommendations and can override
Bias mitigation: AI models tested for disparities across patient demographics
Cross-Border Data Transfer Safeguards: Establish standardized protocols for secure health data transfers between ASEAN nations, ensuring consistent encryption standards, audit trails, and compliance with respective national data protection regulations.
Patient Data Access Rights: Implement mechanisms enabling patients to access, rectify, and request deletion of their health records within defined timeframes, maintaining detailed logs of all data access and modification requests.
Multi-phase testing of AI clinical tools: retrospective validation on historical data, prospective validation with clinician oversight, randomized controlled trials for high-risk applications.
HIPAA-compliant de-identification of patient data before AI model training. Safe Harbor or Expert Determination method. Re-identification risk assessment.
Design requirement: AI provides recommendations, not autonomous decisions. Clinicians retain final authority. AI outputs include confidence scores and supporting evidence.
Pre-deployment testing of AI models for disparities across race, gender, age, socioeconomic status. Fairness metrics documented. Quarterly revalidation.
Post-market surveillance of AI clinical tool performance. Adverse event reporting to FDA/regulatory bodies. Root cause analysis for AI-related patient harm.
Clinical validation study completion
IRB (Institutional Review Board) approval
FDA/regulatory clearance if required
Medical Affairs and Legal review
Hospital/Clinic deployment approval
Required Roles:
Organization-wide policy for AI in clinical care, aligning with HIPAA, FDA medical device regulations, and clinical best practices.
Protocol template for designing AI validation studies including sample size, endpoints, statistical methods, and success criteria.
Step-by-step procedure for testing AI models for demographic bias and documenting fairness metrics.
HIPAA Privacy Rule
De-identify protected health information (PHI) before use or disclosure
Safe Harbor method: remove 18 HIPAA identifiers before AI training. Expert Determination for complex cases. Re-identification risk assessments documented.
FDA 21 CFR Part 820 (Medical Device Quality System)
Design controls for medical device development
AI clinical tools follow design control process: requirements specification, design reviews, verification testing, validation with clinical data, design transfer.
FDA Pre-Cert Program for Software
AI/ML-based medical devices require premarket review
Risk categorization (Class I/II/III). For Class II: 510(k) clearance pathway. Predetermined change control plans for continuous model updates.
Not all. FDA regulates AI as medical devices if they diagnose, treat, or prevent disease. Clinical decision support tools that only provide information (not recommendations) may be exempt. Administrative AI (scheduling, billing) is not regulated. For diagnostic/treatment AI, expect FDA review.
Require: (1) Diverse, representative training data across demographics, (2) Pre-deployment bias testing with fairness metrics (equal accuracy, demographic parity), (3) Quarterly revalidation on new patient populations, (4) Transparent reporting of model limitations, (5) Clinical oversight to catch algorithmic errors.
Depends on de-identification. Under HIPAA, fully de-identified data can be used without consent. Pseudonymized data requires patient authorization or IRB waiver. For research, may qualify for limited data set with data use agreement. Always consult legal counsel and IRB before training on patient data.
Explore articles and research about AI governance best practices
Article
The Philippines National Privacy Commission issued Advisory Guidelines on AI in December 2024, requiring organizations to identify and limit algorithmic bias, prohibit AI washing, and comply with the Data Privacy Act for all AI data processing.
Article
AI governance framework for healthcare organisations in Malaysia and Singapore. Covers patient data protection, clinical AI safety, regulatory compliance, and practical governance controls.
Article
Comprehensive guide to Singapore's AI regulatory landscape, covering the Model AI Governance Framework, PDPA requirements, MAS FEAT principles, and sector-specific compliance obligations for organizations deploying AI systems.
Article
Navigate FDA medical device classification, HIPAA compliance, clinical decision support exemptions, and EU MDR requirements for healthcare AI. Complete guide to diagnostic algorithms, treatment recommendations, and patient safety standards.
We ensure all implementations meet regulatory requirements and industry standards.
Let's discuss how we can help you achieve your AI transformation goals.
Choose your engagement level based on your readiness and ambition
workshop • 1-2 days
Map Your AI Opportunity in 1-2 Days
A structured workshop to identify high-value AI use cases, assess readiness, and create a prioritized roadmap. Perfect for organizations exploring AI adoption. Outputs recommended path: Build Capability (Path A), Custom Solutions (Path B), or Funding First (Path C).
Learn more about Discovery Workshoprollout • 4-12 weeks
Build Internal AI Capability Through Cohort-Based Training
Structured training programs delivered to cohorts of 10-30 participants. Combines workshops, hands-on practice, and peer learning to build lasting capability. Best for middle market companies looking to build internal AI expertise.
Learn more about Training Cohortpilot • 30 days
Prove AI Value with a 30-Day Focused Pilot
Implement and test a specific AI use case in a controlled environment. Measure results, gather feedback, and decide on scaling with data, not guesswork. Optional validation step in Path A (Build Capability). Required proof-of-concept in Path B (Custom Solutions).
Learn more about 30-Day Pilotrollout • 3-6 months
Full-Scale AI Implementation with Ongoing Support
Deploy AI solutions across your organization with comprehensive change management, governance, and performance tracking. We implement alongside your team for sustained success. The natural next step after Training Cohort for middle market companies ready to scale.
Learn more about Implementation Engagementengineering • 3-9 months
Custom AI Solutions Built and Managed for You
We design, develop, and deploy bespoke AI solutions tailored to your unique requirements. Full ownership of code and infrastructure. Best for enterprises with complex needs requiring custom development. Pilot strongly recommended before committing to full build.
Learn more about Custom Buildfunding • 2-4 weeks
Secure Government Subsidies and Funding for Your AI Projects
We help you navigate government training subsidies and funding programs (HRDF, SkillsFuture, Prakerja, CEF/ERB, TVET, etc.) to reduce net cost of AI implementations. After securing funding, we route you to Path A (Build Capability) or Path B (Custom Solutions).
Learn more about Funding Advisoryenablement • Ongoing (monthly)
Ongoing AI Strategy and Optimization Support
Monthly retainer for continuous AI advisory, troubleshooting, strategy refinement, and optimization as your AI maturity grows. All paths (A, B, C) lead here for ongoing support. The retention engine.
Learn more about Advisory Retainer